STAT

Doctors are more tied to pharma as trust erodes

Pfizer is paying $47.50 a share in cash for Metsera, a 43% premium on the startup’s closing price on Friday that gives the ...

Does This Acquisition Make Pfizer Stock a Great Buy?

But -- finally -- Pfizer is getting into the obesity drug game. This past week, the company announced it will acquire Metsera, a clinical-stage biopharmaceutical firm that is developing several ...

Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths

Shares of COVID-19 vaccine makers are trading lower Friday. Vaccine stocks fell Friday on a Washington Post report that Trump ...
STAT

Pig kidneys to enter FDA-backed human trial next year

A positive readout of a Rapport Therapeutics seizure medicine in a mid-stage clinical trial sent company shares soaring, as ...

Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.

These players are vying for positions in the billion-dollar weight loss drug market. Demand for weight loss drugs is soaring, ...